OSCR

SERPINI1 functions as a tumor suppressor in glioma.

Overview

Authors: Shuang Luo1,2,3, Chenyan Du4, Zhongmin Huang4, Hui Wang4, Jialin Chen5, Chong Han6, Hua Feng7, Peng Wang3, Shengtao Yao1,2
  1. Suzhou Medical College of Soochow University, 199 Ren-Ai Road, Suzhou Industrial Park, Suzhou, 215123 Jiangsu China
  2. Department of Neurosurgery, Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Road, Huichuan District, Zunyi, 563000 Guizhou China
  3. Department of Neurosurgery, Cancer Prevention and Treatment Institute of Chengdu, The Second Clinical Medical College, Chengdu Fifth People’s Hospital, Affiliated Fifth People’s Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, Sichuan China
  4. Center for Medicine Research and Translation, Chengdu Fifth People’s Hospital, Chengdu, Sichuan China
  5. The First People’s Hospital of Zunyi, Zunyi, Guizhou China
  6. Zunyi Medical University, Zunyi, Guizhou China
  7. Department of Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University, Chongqing, China
Journal: Scientific reports, volume 16, issue 1, article 25172
Dates: received 12 November 2025; accepted 22 May 2026; published online 2 June 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1038/s41598-026-55196-3 · PMID 42230926 · PMCID PMC13470208 · OpenAlex W7163206579
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: human (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: SERPINI1, Glioma, Tumor suppressor gene, VRK1, VRK3, Cancer, Computational biology and bioinformatics, Oncology
MeSH: Brain Neoplasms*, Glioma*, Serpins*, Tumor Suppressor Proteins*, Cell Line, Tumor, Cell Movement, Cell Proliferation, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Humans, Neuroserpin, Protein Serine-Threonine Kinases (* major topic)
Topic: Cellular transport and secretion (Cell Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: Does the extracted text look correct compared to your manuscript? (No.2024372); Fund for Less Developed Regions of the National Natural Science Foundation of China (No.82260247)
Citations: not cited yet (Europe PMC); 32 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the data are available on request

Read it in the paper: doi.org/10.1038/s41598-026-55196-3.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 8 keywords, 12 MeSH terms, 2 funders, 32 references.

Cite

This paper

Luo, S., Du, C., Huang, Z., Wang, H., Chen, J., Han, C., Feng, H., Wang, P., & Yao, S. (2026). SERPINI1 functions as a tumor suppressor in glioma. Scientific reports, 16(1), 25172. https://doi.org/10.1038/s41598-026-55196-3

BibTeX

@article{luo2026serpini1,
author = {Luo, Shuang and Du, Chenyan and Huang, Zhongmin and Wang, Hui and Chen, Jialin and Han, Chong and Feng, Hua and Wang, Peng and Yao, Shengtao},
title = {{SERPINI1 functions as a tumor suppressor in glioma}},
journal = {Scientific reports},
year = {2026},
month = jun,
volume = {16},
number = {1},
pages = {25172},
publisher = {Nature Publishing Group},
issn = {2045-2322},
doi = {10.1038/s41598-026-55196-3},
url = {https://doi.org/10.1038/s41598-026-55196-3},
pmid = {42230926},
pmcid = {PMC13470208}
}

RIS

TY - JOUR
AU - Luo, Shuang
AU - Du, Chenyan
AU - Huang, Zhongmin
AU - Wang, Hui
AU - Chen, Jialin
AU - Han, Chong
AU - Feng, Hua
AU - Wang, Peng
AU - Yao, Shengtao
TI - SERPINI1 functions as a tumor suppressor in glioma
T2 - Scientific reports
J2 - Sci Rep
PY - 2026
DA - 2026/06/02
VL - 16
IS - 1
SP - 25172
SN - 2045-2322
PB - Nature Publishing Group
DO - 10.1038/s41598-026-55196-3
UR - https://doi.org/10.1038/s41598-026-55196-3
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s41598-026-55196-3",
"type": "article-journal",
"title": "SERPINI1 functions as a tumor suppressor in glioma",
"container-title": "Scientific reports",
"author": [
{
"family": "Luo",
"given": "Shuang"
},
{
"family": "Du",
"given": "Chenyan"
},
{
"family": "Huang",
"given": "Zhongmin"
},
{
"family": "Wang",
"given": "Hui"
},
{
"family": "Chen",
"given": "Jialin"
},
{
"family": "Han",
"given": "Chong"
},
{
"family": "Feng",
"given": "Hua"
},
{
"family": "Wang",
"given": "Peng"
},
{
"family": "Yao",
"given": "Shengtao"
}
],
"container-title-short": "Sci Rep",
"volume": "16",
"issue": "1",
"page": "25172",
"DOI": "10.1038/s41598-026-55196-3",
"PMID": "42230926",
"PMCID": "PMC13470208",
"ISSN": "2045-2322",
"publisher": "Nature Publishing Group",
"URL": "https://doi.org/10.1038/s41598-026-55196-3",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
2
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s13293-026-00927-4 [code]
Gene regulatory network analysis identifies dysregulation of hypoxia pathways as contributing to glioblastoma treatment resistance in females.
Journal: Biology of sex differences
In common: NCBI GEO GSE108474, other condition, cellular / molecular
[2] doi:10.1016/j.isci.2026.115982 [code]
Multi-omics profiling-derived signature links cellular ecosystem to glioblastoma prognosis.
Journal: iScience
In common: other condition, 3 references
[3] doi:10.3390/cancers18132092
TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activated Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study.
Journal: Cancers
In common: other condition, 3 references
[4] doi:10.1186/s40478-026-02318-7
Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation.
Journal: Acta neuropathologica communications
In common: other condition, cellular / molecular, 2 references
[5] doi:10.1038/s41467-026-74058-0
IQGAP3 bridges matrix stiffness with glioma stem cell maintenance and radioresistance by stabilizing SOX2.
Journal: Nature communications
In common: other condition, cellular / molecular, 2 references
[6] doi:10.32604/or.2026.079221
Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target.
Journal: Oncology research
In common: other condition, cellular / molecular, 2 references
[7] doi:10.3390/ijms27167240
1-Piperidine Propionic Acid Inhibits PAR2/SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness.
Journal: International journal of molecular sciences
In common: other condition, cellular / molecular, 2 references
[8] doi:10.1080/17501911.2026.2691031
Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.
Journal: Epigenomics
In common: other condition, cellular / molecular, 2 references
[9] doi:10.3390/biology15141179
Transcriptomic Evidence Identifies Two TMBIM Subgroups with Opposing Prognostic Associations in Glioma.
Journal: Biology
In common: other condition, 2 references
[10] doi:10.2147/ijgm.s605071
Mendelian Randomization and Single-Cell RNA Sequencing Reveal CKAP4 and PFDN5 as Tumor Cell-Specific Causal Genes for Glioblastoma.
Journal: International journal of general medicine
In common: other condition, cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.